ORIC Pharmaceuticals (ORIC) News Today → Trump Asset Seizure Threat Alert: Could Your Savings Be Next? (From American Hartford Gold Group) (Ad) Free ORIC Stock Alerts $9.60 -0.01 (-0.10%) (As of 05/8/2024 ET) Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainabilityStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainability All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative SourceHeadlineWedbush Weighs in on ORIC Pharmaceuticals, Inc.'s Q2 2024 Earnings (NASDAQ:ORIC)americanbankingnews.com - May 9 at 6:36 AMCitigroup Lowers ORIC Pharmaceuticals (NASDAQ:ORIC) Price Target to $14.00americanbankingnews.com - May 9 at 4:22 AMBuy Rating on Oric Pharmaceuticals Amidst Strong Financials and Promising Clinical Pipelinemarkets.businessinsider.com - May 8 at 10:58 PMORIC Pharmaceuticals Incmorningstar.com - May 8 at 5:58 PMWe Think ORIC Pharmaceuticals (NASDAQ:ORIC) Can Afford To Drive Business Growthfinance.yahoo.com - May 8 at 9:06 AMBuy Rating Affirmed for Oric Pharmaceuticals Amid Promising Clinical Data and Strong Financial Positionmarkets.businessinsider.com - May 7 at 11:06 PMAnalysts Are Bullish on Top Healthcare Stocks: Stoke Therapeutics (STOK), Oric Pharmaceuticals (ORIC)markets.businessinsider.com - May 7 at 6:05 PMORIC Pharmaceuticals, Inc. (NASDAQ:ORIC) Given Consensus Recommendation of "Buy" by Analystsmarketbeat.com - May 7 at 4:29 PMORIC Pharmaceuticals (NASDAQ:ORIC) Shares Up 6.5%marketbeat.com - May 7 at 3:23 PMORIC Stock Earnings: ORIC Pharmaceuticals Beats EPS for Q1 2024investorplace.com - May 6 at 10:08 PMORIC Pharmaceuticals (NASDAQ:ORIC) Stock Price Down 3.5%marketbeat.com - May 6 at 7:33 PMORIC Pharmaceuticals Reports First Quarter 2024 Financial Results and Operational Updatesglobenewswire.com - May 6 at 4:05 PMORIC Pharmaceuticals Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)globenewswire.com - May 3 at 4:30 PMORIC Pharmaceuticals (NASDAQ:ORIC) Shares Up 5.8%marketbeat.com - April 30 at 1:37 PMORIC Pharmaceuticals (NASDAQ:ORIC) Stock Price Down 5.6%marketbeat.com - April 24 at 7:14 PMORIC Pharmaceuticals (NASDAQ:ORIC) Trading Down 4%marketbeat.com - April 18 at 1:56 PMORIC Pharmaceuticals (NASDAQ:ORIC) Shares Up 4.2%marketbeat.com - April 17 at 1:52 PMORIC Pharmaceuticals Announces First Patients Dosed Across Three Expansion Cohorts in Phase 1b Trial of ORIC-114 in Patients with Mutated NSCLCglobenewswire.com - April 15 at 4:15 PMORIC Pharmaceuticals (NASDAQ:ORIC) Shares Down 2.6% marketbeat.com - April 8 at 11:59 AMORIC Pharmaceuticals Presents Preclinical Data on Two Programs at the 2024 American Association for Cancer Research (AACR) Annual Meetingglobenewswire.com - April 8 at 8:00 AMORIC Pharmaceuticals Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)globenewswire.com - April 5 at 4:30 PMORIC Pharmaceuticals to Participate in Upcoming Investor Conferencesglobenewswire.com - April 4 at 4:30 PMORIC Pharmaceuticals (NASDAQ:ORIC) Trading Down 6.3%marketbeat.com - April 1 at 3:48 PMORIC Pharmaceuticals: Rally Seems Overdoneseekingalpha.com - March 29 at 5:29 AMORIC Pharmaceuticals (NASDAQ:ORIC) PT Lowered to $18.00marketbeat.com - March 27 at 10:59 AMOric Pharmaceuticals: Sustained Buy Rating Amid Strong Financials and Upcoming Catalystsmarkets.businessinsider.com - March 21 at 7:27 PMORIC Pharmaceuticals (NASDAQ:ORIC) Shares Gap Up Following Analyst Upgrademarketbeat.com - March 21 at 10:28 AMHC Wainwright Increases ORIC Pharmaceuticals (NASDAQ:ORIC) Price Target to $21.00marketbeat.com - March 21 at 8:21 AMORIC Pharmaceuticals stock target raised to $17 on strong prospectsinvesting.com - March 14 at 6:20 PMORIC Pharmaceuticals (NASDAQ:ORIC) Trading 7.9% Higher marketbeat.com - March 13 at 1:51 PMORIC Pharmaceuticals: Mid-2024 Prostate Cancer Program Update Could Lead To Gainsseekingalpha.com - March 13 at 10:39 AMORIC Pharmaceuticals Inc (ORIC) Reports Q4 and Full Year 2023 Financial Resultsfinance.yahoo.com - March 12 at 11:24 PMEuclidean Capital LLC Raises Holdings in ORIC Pharmaceuticals, Inc. (NASDAQ:ORIC)marketbeat.com - March 12 at 2:44 PMThese Analysts Revise Their Forecasts On ORIC Pharmaceuticals After Q4 Resultsmarkets.businessinsider.com - March 12 at 1:24 PMORIC Pharmaceuticals (NASDAQ:ORIC) Issues Earnings Results, Hits Estimatesmarketbeat.com - March 12 at 8:56 AMORIC Pharmaceuticals GAAP EPS of -$0.49msn.com - March 11 at 10:03 PMORIC Pharmaceuticals Reports Fourth Quarter and Full Year 2023 Financial Results and Operational Updatesglobenewswire.com - March 11 at 4:05 PMORIC Pharmaceuticals Inc CEO Jacob Chacko Sells 40,000 Sharesfinance.yahoo.com - March 8 at 6:30 PMORIC Pharmaceuticals (NASDAQ:ORIC) Shares Down 5.5% marketbeat.com - March 8 at 2:16 PMORIC Mar 2024 2.500 putfinance.yahoo.com - March 7 at 10:18 AMORIC Pharmaceuticals to Present at the Leerink Partners Global Biopharma Conferencefinance.yahoo.com - March 6 at 6:01 PMORIC Pharmaceuticals to Present at the Leerink Partners Global Biopharma Conferenceglobenewswire.com - March 6 at 4:30 PMORIC Pharmaceuticals to Present at the Leerink Partners Global Biopharma Conferenceglobenewswire.com - March 6 at 4:30 PMORIC Pharmaceuticals (NASDAQ:ORIC) Hits New 12-Month High at $16.10marketbeat.com - March 6 at 10:44 AMORIC Pharmaceuticals Announces Multiple Presentations at the 2024 American Association for Cancer Research (AACR) Annual Meetingglobenewswire.com - March 5 at 4:30 PMFmr LLC Sells 600,054 Shares of ORIC Pharmaceuticals, Inc. (NASDAQ:ORIC)marketbeat.com - March 5 at 6:27 AMAcadian Asset Management LLC Decreases Holdings in ORIC Pharmaceuticals, Inc. (NASDAQ:ORIC)marketbeat.com - March 4 at 5:28 AMORIC Apr 2024 10.000 callfinance.yahoo.com - March 3 at 11:26 PMORIC Mar 2024 15.000 putfinance.yahoo.com - March 3 at 6:26 PMAlkeon Capital Management LLC Has $21.05 Million Stake in ORIC Pharmaceuticals, Inc. (NASDAQ:ORIC)marketbeat.com - March 3 at 11:41 AM Get ORIC Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for ORIC and its competitors with MarketBeat's FREE daily newsletter. Email Address The 2024 Gold Rush: Unleashing Market Potential (Ad)Welcome to the financial rollercoaster of 2024, where inflation is persistent, stock markets are overinflated and volatile, global conflicts are intensifying, and the national debt is reaching new heights. Get your free information kit NOW, before it's too late. ORIC Media Mentions By Week ORIC Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. ORIC News Sentiment▼0.640.36▲Average Medical News Sentiment ORIC News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. ORIC Articles This Week▼142▲ORIC Articles Average Week Get ORIC Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for ORIC and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: Lyell Immunopharma News Today Pharming Group News Today Zymeworks News Today Silence Therapeutics News Today Olema Pharmaceuticals News Today GH Research News Today CureVac News Today Stoke Therapeutics News Today Phibro Animal Health News Today Calliditas Therapeutics AB (publ) News Today Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:ORIC) was last updated on 5/9/2024 by MarketBeat.com Staff From Our PartnersTech GIANT’s Plans to Revolutionize Crypto…Crypto 101 MediaThis 1 Biotech Stock has been shocking the marketsHuge AlertsExposed: 10 CENT Crypto to Explode May 20th?True Market InsidersThe 2024 Gold Rush: Unleashing Market PotentialPriority GoldDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsUrgent Nvidia WarningAltimetry348 million Americans lives to END as we know it?The Oxford ClubThe A.I. story nobody is telling you (Read ASAP)TradeSmith Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding ORIC Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
